| 前收市價 | 211.25 |
| 開市 | 0.00 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 0.00 - 0.00 |
| 52 週波幅 | |
| 成交量 | |
| 平均成交量 | 1,650 |
| 市值 | 41.434B |
| Beta 值 (5 年，每月) | 1.54 |
| 市盈率 (最近 12 個月) | 0.38 |
| 每股盈利 (最近 12 個月) | 5.54 |
| 業績公佈日 | 2024年7月30日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
ZacksClinical Development Expertise Aids IQVIA (IQV), Costs High
IQVIA (IQV) benefits from its healthcare-specific global IT infrastructure and domain expertise to expand and penetrate different markets.
ZacksPaychex (PAYX) to Report Q4 Earnings: What's in the Offing?
Paychex's (PAYX) fourth-quarter fiscal 2024 earnings and revenues are expected to have increased year over year.
ZacksIQVIA (IQV) Announces Launch of Trial Technology Platform
IQVIA's (IQV) One Home for Sites allows pharmaceutical companies and their software vendors to streamline clinical application management.
